重复肾活检在狼疮性肾炎中的价值:单中心经验
该单中心回顾性研究评估了66例系列肾活检的狼疮性肾炎患者,发现非增殖性向增殖性转型常见且更易强化免疫抑制,肾小管间质评分进展且与血肌酐相关,提示重复活检有助指导治疗。
要点
- 非增殖性向增殖性转型常见,且更可能接受强化免疫抑制。
- 生化或血清学指标无法预测病理转型。
- 血肌酐与肾小管间质损伤程度相关。
核心结论
- 重复肾活检是指导狼疮性肾炎管理的重要工具,尤其对初始为II或V类且出现复发的患者。
研究设计与样本
- 单中心队列研究,270例活检证实的狼疮性肾炎患者中66例(24%)有系列肾活检。
主要发现
- 增殖性向非增殖性转型不常见(n=4,7.7%)。
- 非增殖性向增殖性转型常见(n=12,63.2%),且更可能接受强化免疫抑制(P=0.040)。
- 生化或血清学变量无法预测组织病理学转型。
- 肾小管间质评分从参考活检的2.69±2.03进展至重复活检的3.78±2.03(P=0.001)。
- 血肌酐水平与参考活检(r=0.33,P=0.048)及重复活检(r=0.56,P<0.001)的肾小管萎缩程度相关,与重复活检的间质纤维化相关(r=0.60,P<0.001)。
关键数值与推荐
- 狼疮性肾炎分类依据国际肾脏病学会/肾脏病理学会2003分类。
- 肾小管间质病理采用修订的Austin半定量评分系统评估。
临床怎么用
- 对初始为II或V类且出现复发的狼疮性肾炎患者,可考虑重复肾活检以指导治疗决策。
- 血肌酐可用于提示肾小管间质损伤程度,但不能替代活检预测病理转型。
局限性
- 单中心回顾性设计,仅24%的患者有系列活检,样本量有限。
- 未报告多因素分析或长期结局,无法确定重复活检对硬终点的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The role of repeat renal biopsy in lupus nephritis (LN) to guide treatment or predict prognosis has been controversial. We assessed glomerular and tubulointerstitial histological characteristics of serial renal biopsies, correlations with clinical variables and the impact on subsequent management. METHODS: Out of a large single-centre cohort of 270 biopsy-proven LN patients, 66 (24%) had serial biopsies. LN classes based on glomerular pathology were defined according to the International Society of Nephrology/Renal Pathology Society 2003 classification, while tubulointerstitial pathologies were evaluated using the revised Austin's semi-quantitative scoring system. RESULTS: LN class transitions from proliferative (III and IV) to non-proliferative classes (II and V) were uncommon (n = 4, 7.7%), while non-proliferatives frequently switched to proliferative classes (n = 12, 63.2%) and were more likely to receive increased immunosuppression (P = 0.040). Biochemical or serological variables could not predict these histopathological transitions. Tubulointerstitial score (mean ± standard deviation) progressed from 2.69 ± 2.03 on reference to 3.78 ± 2.03 on repeat biopsy (P = 0.001). Serum creatinine levels correlated with the degree of tubular atrophy on both reference (r = 0.33, P = 0.048) and repeat biopsy (r = 0.56, P < 0.001), and with interstitial scarring (r = 0.60, P < 0.001) on repeat biopsy. Greater interstitial inflammation on reference biopsy was associated with advanced interstitial scarring on repeat biopsies (r = 0.385, P = 0.009). CONCLUSIONS: Repeat renal biopsy is an important tool to guide management, in particular in those with initial class II or V who flare. Although class transitions cannot be predicted by clinical parameters, serum creatinine level correlates with the degree of tubulointerstitial damage.
引用
- Pakozdi A, Pyne D, Sheaff M, et al. Utility of a repeat renal biopsy in lupus nephritis: a single centre experience. Nephrol Dial Transplant. 2018. PMID: 28444337. doi:10.1093/ndt/gfx019
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。